Cheng Han Ng
@ChengHanNg
Followers
1K
Following
22K
Media
233
Statuses
1K
Physician, Biotech & Researcher of Metabolic Diseases | RT =/ Support
Right Upper Quadrant
Joined January 2021
#GITwitter #LiverTwitterSo happy to be listed among the Stanford top 2% scientists! 🎉 Extremely thankful to my amazing mentors for their guidance and support in helping me achieve this at 27! 🙏✨
3
2
29
📊 At just 27, I’ve published 200+ research papers. One of the biggest reasons? My mentor Nicholas Syn. He created a 4-hour, jam-packed course on meta-analysis the same strategies that shaped my career! 📷 Use code META50 for 50% off .
1
2
15
0
0
5
RT @ChengHanNg: 🌍 Our first online meeting for CORE (Cirrhosis Outcomes & Research Endeavors)! Founded by Myself, @DrMarkMuthiah and Hiroka….
0
1
0
🌍 Our first online meeting for CORE (Cirrhosis Outcomes & Research Endeavors)! Founded by Myself, @DrMarkMuthiah and Hirokazu Takahashi, CORE united 11 sites (🇸🇬🇺🇸🇮🇳🇨🇳🇭🇰🇹🇭🇯🇵🇺🇸🇸🇬🇹🇭🇮🇳) to study compensated cirrhosis with 3500+ patients, with more joining soon from 🇺🇸🇰🇷🇦🇺🇬🇧 🇯🇵🇯🇵.
1
1
19
RT @DrHuangDQ: In this consortium study of academic centres in Singapore, Japan, Korea, and Australia @JAMANetworkOpen by @NUSMedicine stud….
0
9
0
RT @Drwenhaoli: @ChengHanNg @JAMANetworkOpen We also found the same in our multi-centre UK study!! Aetiology clearly plays an important rol….
pubmed.ncbi.nlm.nih.gov
HCC surveillance as currently delivered was less effective for detecting early-stage HCC in patients with non-viral and non-cirrhotic liver disease. Gender and ethnicity influences stage at present...
0
2
0
RT @ChengHanNg: Just published Our international study of 1,185 patients in @JAMANetworkOpen shows that HCC surveillance is linked to bette….
0
2
0
Just published Our international study of 1,185 patients in @JAMANetworkOpen shows that HCC surveillance is linked to better survival, especially in those with HBV- or HCV-related liver cancer. Less clear benefit in MASLD/alcohol-related HCC. Liver Etiology matters!
1
2
15
RT @APandT: Read open access via - "Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Allel….
0
10
0
RT @ChengHanNg: Thank you V Chen for inviting me! Genetic variants in PNPLA3, TM6SF2, MBOAT7 significantly linked to worse hepatic outcomes….
0
7
0
Thank you V Chen for inviting me! Genetic variants in PNPLA3, TM6SF2, MBOAT7 significantly linked to worse hepatic outcomes in #SLD. 📌 PNPLA3-GG → ↑ liver mortality (sHR 2.83).📌 TM6SF2-T → ↑ HCC (sHR 2.12).📌 MBOAT7-TT → ↑ MALO. 🔗
0
7
17
RT @ChengHanNg: #LiverTwitter Only 1 in 3 countries have national policies targeting #HCC! Fewer than 1 in 10 address MASLD, despite its gr….
0
2
0
#LiverTwitter Only 1 in 3 countries have national policies targeting #HCC! Fewer than 1 in 10 address MASLD, despite its growing global burden but >90% focus on HBV/HCV. 📉 Policy gaps are stark & 📈 Action is urgent. 🔗
0
2
6
RT @Bio_youtuber: Just a while ago, this was a tiny account with only 10 followers. Thanks to @Biotech2k1 and an amazing biotech investing….
0
2
0
RT @ChengHanNg: #ILTS2025 @_ILTS_ Looking forward to meeting colleagues and experts at the #ILTS2025 conference! If there's anyone requirin….
0
1
0
RT @ChengHanNg: Honored to be named a 2024 Top Scholar by ScholarGPS, recognizing the top 0.5% of researchers globally at 28yo!. Grateful t….
0
1
0
Honored to be named a 2024 Top Scholar by ScholarGPS, recognizing the top 0.5% of researchers globally at 28yo!. Grateful to all who’ve shared in this journey—your support means everything. Onward, and always open to new collaborations. 🔬✨ #Liver #metabolism #HCC
4
1
19
RT @DrHuangDQ: In this international, collaborative effort led by Douglas Chee, we estimate the presence of health policies directed at red….
0
13
0